Quote:
Originally Posted by GGG
The Moderna RSV vaccine is currently sitting with the FDA for approval. Phase 3 testing is complete. Two non-MNRA vaccines have been approved this past year for RSV.
|
But not yet rolled out.
So the anecdote of "its rare to get myocarditis" or other adverse ailments from mRNA vaccines must only apply to covid shots from the last couple of years.
Not a long time frame to build long term data sets to be making conclusive statements on effects such as myocarditis.